Antibodies against glutamic acid decarboxylase: Prevalence in neurological diseases

Journal of Neurology Neurosurgery and Psychiatry

Volumn 71, Issue 1, 2001, Pages 100-103

  Meinck, H M ^a   Faber, L ^a   Morgenthaler, N ^b   Seissler, J ^b   Maile, S ^a   Butler, M ^c   Solimena, M ^c   DeCamilli, P ^c   Scherbaum, W A ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Glutamic acid decarboxylase; Stiff man syndrome

Indexed keywords

GLUTAMATE DECARBOXYLASE;

ANTIBODY BLOOD LEVEL; ARTICLE; CEREBROVASCULAR ACCIDENT; ENCEPHALOMYELITIS; EXTRAPYRAMIDAL SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MYOCLONUS; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; NEUROMUSCULAR DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RIGIDITY;

ANTIBODIES; GLUTAMATE DECARBOXYLASE; HUMANS; NERVOUS SYSTEM DISEASES; PREVALENCE; RADIOIMMUNOASSAY;

EID: 0034963362     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.71.1.100     Document Type: Article

References (20)

1. Mugnaini E, Oertel WH. An atlas on the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In: Björklund A, Hökfelt T, eds. Handbook of chemical neuroanatomy. Vol 4, part 1. Amsterdam: Elsevier, 1985:436-608.
2. Solimena M, Folli F, Aparisi R, et al. Autoamibodies to GABAergic neurons and pancreatic β cells in stiff-man syndrome. N Engl J Med 1990;322:1555-60.
3. Stayer C, Meinck HM. Stiff-man syndrome: an overview. Neurologia 1998;13:83-8.
4. Dinkel K, Meinck HM, Jury KM, et al.. Inhibition of γ-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff man syndrome. Ann Neurol 1998;44:194-201.
5. Honnorat J, Trouillas P, Thivolet C, et al. Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements. Arch Neurol 1995;52:462-8.
6. Saiz A, Arpa J, Sagasta A, et al.. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late onset insulin dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 1997;49:1026-30.
7. Abele M, Weller M, Mescheriakov S, et al.. Cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Neurology 1999;52:857-9.
8. Nemni R, Braghi S, Natali-Sora MG, et al.. Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol 1994;36:665-7.
9. Giometto B, Nicolao P, Macucci M, et al.. Temporal lobe epilepsy associated with glutamic acid decarboxylase autoantibodies. Lancet 1998;352:457.
10. Peltola J; Kulmala P, Isojärvi J, et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy resistant epilepsy. Neurology 2000;55:46-50.
11. Trivedi R, Mundanthanam G, Amyes E, et al. Autoantibody screening in subacute cerebellar ataxia. Lancet 2000;356: 565-6.
12. Seissler J, Morgenthaler NG, Achenbach P, et al. Combined screening for autoantibodies to IA-2 and antibodies to gtlutamic acid decarboxylase in first degree relatives of patients with IDDM. Diabetologia 1996;39:1351-6.
13. Schmidli RS, Colman PG, Bonifacio E. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. Diabetes 1995;44:636-40.
14. Seissler J, Bieg S, Yassin N, et al. Association between antibodies to the MR 67 000 isoform of glutamate decarboxylase (GAD) and type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune poyendocrine syndrome type II. Autoimmunity 1994;19:231-8.
15. Schmidli RS, DeAizpurua HJ, Harrison LC, et al.. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile. J Autoimmun 1994;7:55-66.
16. Grimaldi LME, Martino G, Braghi S, et al.. Heterogeneity of autoantibodies in stiff-man syndrome. Ann Neurol 1993; 34:57-64.
17. Butler MH, Solimena M, Dirkx RJr, et al. Identification of a dominant epitope of glutamate decarboxylase (GAD65) recognized by autoantibodies in stiff-man syndrome. J Exp Med 1993;178:2097-106.
18. Soghomonian JJ, Martin DL. Two isoforms of glutamate decarboxylase: why? TiPS 1998;19:500-5.
19. Steffen H, Menger N, Richter W, et al. Immune-mediated retinopathy in a patient with stiff-man syndrome. Graefe's Arch Clin Exp Ophthalmol 1999;237:212-19.
20. Honeyman MC, Stone N, DeAizpurua H, et al. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes. J Autoimmun 1997;10: 165-73.